Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conjunctiva; Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07198126
What this trial is testing

Comparison Of Keratometric Readings Pre and Post Pterygium Excision With Conjunctival Autograft Transplantation

Who this might be right for
PterygiumCorneal Astigmatism
Mughal Eye Trust Hospital 130
Large-scale testing (Phase 3)Not Yet RecruitingNCT06985875
What this trial is testing

Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4%

Who this might be right for
Eye Dryness
Avizor SA 79
Not applicableStudy completedNCT03753893
What this trial is testing

Ocular Manifestations in Rheumatic Diseases

Who this might be right for
UveitisConjunctivitisKeratoconjunctivitis Sicca+15 more
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 5,000
Not applicableEnded earlyNCT04654325
What this trial is testing

Prevalence of SARS-CoV-2 Genome in Tears of Asymptomatic and Moderately Symptomatic COVID-19 Patients

Who this might be right for
SARS-CoV-2
Assistance Publique - Hôpitaux de Paris 534
Not applicableUnknownNCT03314389
What this trial is testing

The Corneal and Conjunctiva Sensation Before and After Pterygium Surgeries

Who this might be right for
Pterygium
Sheba Medical Center 100
Large-scale testing (Phase 3)Study completedNCT02161146
What this trial is testing

AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Who this might be right for
Conjunctivitis, Allergic
Allergan 240
Post-approval studies (Phase 4)Study completedNCT00357019
What this trial is testing

Study of the Clinical and Biological Efficacity of NAAXIA SINE® in Vernal Keratoconjunctivitis

Who this might be right for
Keratoconjunctivitis, Vernal
Laboratoires Thea
Post-approval studies (Phase 4)Study completedNCT02048007
What this trial is testing

Mortality Reduction After Oral Azithromycin: Morbidity Study

Who this might be right for
Childhood Mortality
University of California, San Francisco 72,000
Early research (Phase 1)Study completedNCT01733992
What this trial is testing

A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye Disease

Who this might be right for
Keratoconjunctivitis Sicca
Rigel Pharmaceuticals 36
Post-approval studies (Phase 4)Study completedNCT01443442
What this trial is testing

Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Southern California College of Optometry at Marshall B. Ketchum University 23
Large-scale testing (Phase 3)Study completedNCT01685242
What this trial is testing

A Single-Center,Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle

Who this might be right for
Allergic Conjunctivitis
Aciex Therapeutics, Inc. 100
Testing effectiveness (Phase 2)WithdrawnNCT00375596
What this trial is testing

The Safety And Effectiveness Of A New Treatment For Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Bausch & Lomb Incorporated
Not applicableUnknownNCT04346160
What this trial is testing

Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tears of Patients Affected by COVID-19 Disease

Who this might be right for
COVIDConjunctivitis
G. d'Annunzio University 25
Testing effectiveness (Phase 2)Study completedNCT06293820
What this trial is testing

TL-925 For The Treatment of AC

Who this might be right for
Allergic Conjunctivitis
Telios Pharma, Inc. 80
Large-scale testing (Phase 3)Study completedNCT02845674
What this trial is testing

An Open-Label Extension of a Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca

Who this might be right for
Keratoconjunctivitis Sicca
Sun Pharmaceutical Industries Limited 258
Not applicableStudy completedNCT04117386
What this trial is testing

Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium

Who this might be right for
Human Papilloma Virus InfectionPterygium
Chulalongkorn University 141
Post-approval studies (Phase 4)WithdrawnNCT00286026
What this trial is testing

Azithromycin in Control of Trachoma II

Who this might be right for
Trachoma
University of California, San Francisco
Large-scale testing (Phase 3)Study completedNCT00244543
What this trial is testing

Evaluation of Efficacy of Ophthalmic Solution in Induced Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
Vistakon Pharmaceuticals 110
Not applicableStudy completedNCT06944132
What this trial is testing

CsA vs MMC for Preventing Pterygium Recurrence

Who this might be right for
PterygiumPterygium of the Conjunctiva and Cornea
Benha University 40
Not applicableUnknownNCT06200727
What this trial is testing

Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

Who this might be right for
Platelet-rich FibrinMacular HolesPterygium+1 more
Lei Du 170
Next Page